223 related articles for article (PubMed ID: 33348839)
21. Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection.
Sacchi P; Cima S; Corbella M; Comolli G; Chiesa A; Baldanti F; Klersy C; Novati S; Mulatto P; Mariconti M; Bazzocchi C; Puoti M; Pagani L; Filice G; Bruno R
Dig Liver Dis; 2015 Mar; 47(3):218-25. PubMed ID: 25544657
[TBL] [Abstract][Full Text] [Related]
22. Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.
Vidovic N; Lochowsky RS; Goldmann G; Rockstroh J; Wasmuth JC; Spengler U; Sauerbruch T; Lammert F; Oldenburg J; Grünhage F
Haemophilia; 2010 Sep; 16(5):778-85. PubMed ID: 20331759
[TBL] [Abstract][Full Text] [Related]
23. IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection.
Jiménez-Sousa MA; Berenguer J; Rallón N; Pineda-Tenor D; Aldamiz-Echevarria T; Soriano V; García-Álvarez M; Vazquez-Morón S; Restrepo C; Carrero A; Benito JM; Resino S
Liver Int; 2016 Sep; 36(9):1258-66. PubMed ID: 26836972
[TBL] [Abstract][Full Text] [Related]
24. Plasma IP-10 and IL-6 are linked to Child-Pugh B cirrhosis in patients with advanced HCV-related cirrhosis: a cross-sectional study.
Salgüero S; Medrano LM; González-García J; Berenguer J; Montes ML; Diéz C; Garcia-Broncano P; Llop-Herrera E; Pérez-Latorre L; Bellóno JM; Jiménez-Sousa MÁ; Resino S
Sci Rep; 2020 Jun; 10(1):10384. PubMed ID: 32587340
[TBL] [Abstract][Full Text] [Related]
25. Decreases in markers of monocyte/macrophage activation after hepatitis C eradication in HIV/hepatitis C virus coinfected women.
French AL; Grennan D; Daubert E; Seaberg EC; Peters M; Augenbraun M; Fischl M; Kassaye S; Franco R; Kuniholm M; Adimora AA; Workowski K; Weber KM
AIDS; 2021 Jul; 35(9):1433-1438. PubMed ID: 33710024
[TBL] [Abstract][Full Text] [Related]
26. Influence of Hepatitis C Virus Sustained Virological Response on Immunosuppressive Tryptophan Catabolism in ART-Treated HIV/HCV Coinfected Patients.
Jenabian MA; Mehraj V; Costiniuk CT; Vyboh K; Kema I; Rollet K; Paulino Ramirez R; Klein MB; Routy JP
J Acquir Immune Defic Syndr; 2016 Mar; 71(3):254-62. PubMed ID: 26436613
[TBL] [Abstract][Full Text] [Related]
27. Impact of lifetime alcohol use on liver fibrosis in a population of HIV-infected patients with and without hepatitis C coinfection.
Fuster D; Tsui JI; Cheng DM; Quinn EK; Bridden C; Nunes D; Libman H; Saitz R; Samet JH
Alcohol Clin Exp Res; 2013 Sep; 37(9):1527-35. PubMed ID: 23647488
[TBL] [Abstract][Full Text] [Related]
28. Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study.
Focà E; Fabbiani M; Prosperi M; Quiros Roldan E; Castelli F; Maggiolo F; Di Filippo E; Di Giambenedetto S; Gagliardini R; Saracino A; Di Pietro M; Gori A; Sighinolfi L; Pan A; Postorino MC; Torti C;
Medicine (Baltimore); 2016 Jul; 95(29):e4091. PubMed ID: 27442636
[TBL] [Abstract][Full Text] [Related]
29. Reproductive Aging and Hepatic Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women.
Sarkar M; Dodge JL; Greenblatt RM; Kuniholm MH; DeHovitz J; Plankey M; Kovacs A; French AL; Seaberg EC; Ofotokun I; Fischl M; Overton E; Kelly E; Bacchetti P; Peters MG;
Clin Infect Dis; 2017 Oct; 65(10):1695-1702. PubMed ID: 29020239
[TBL] [Abstract][Full Text] [Related]
30. Macrophage Activation and the Tumor Necrosis Factor Cascade in Hepatitis C Disease Progression Among HIV-Infected Women Participating in the Women's Interagency HIV Study.
French AL; Martin JW; Evans CT; Peters M; Kessaye SG; Nowicki M; Kuniholm M; Golub E; Augenbraun M; Desai SN;
J Acquir Immune Defic Syndr; 2017 Dec; 76(4):438-444. PubMed ID: 29077674
[TBL] [Abstract][Full Text] [Related]
31. Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C.
Valcour VG; Rubin LH; Obasi MU; Maki PM; Peters MG; Levin S; Crystal HA; Young MA; Mack WJ; Cohen MH; Pierce CB; Adimora AA; Tien PC;
J Acquir Immune Defic Syndr; 2016 Jul; 72(3):266-73. PubMed ID: 26885801
[TBL] [Abstract][Full Text] [Related]
32. Fibrosis-4 index predicts mortality in HIV/HCV co-infected patients receiving combination antiretroviral therapy in rural China.
Chen X; Liu X; Tang R; Ye R; Yang Y; Yao S; Wang J; Ding Y; Duan S; He N
Biosci Trends; 2019 Mar; 13(1):32-39. PubMed ID: 30726798
[TBL] [Abstract][Full Text] [Related]
33. Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapy.
Fuster D; Planas R; Muga R; Ballesteros AL; Santos J; Tor J; Sirera G; Guardiola H; Salas A; Cabré E; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Tural C
AIDS Res Hum Retroviruses; 2004 Dec; 20(12):1293-7. PubMed ID: 15650421
[TBL] [Abstract][Full Text] [Related]
34. Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study.
Armah KA; Quinn EK; Cheng DM; Tracy RP; Baker JV; Samet JH; Freiberg MS
BMC Infect Dis; 2013 Aug; 13():399. PubMed ID: 23987993
[TBL] [Abstract][Full Text] [Related]
35. Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline.
Sanmartín R; Tor J; Sanvisens A; López JJ; Jou A; Muga R; Ojanguren I; Barluenga E; Videla S; Planas R; Clotet B; Tural C
HIV Med; 2014 Apr; 15(4):203-12. PubMed ID: 24245909
[TBL] [Abstract][Full Text] [Related]
36. Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study.
Desai SN; Dodge JL; Landay AL; Glesby MJ; Latham PS; Villacres MC; French AL; Gange SJ; Greenblatt RM; Peters MG
Medicine (Baltimore); 2016 Aug; 95(33):e4483. PubMed ID: 27537569
[TBL] [Abstract][Full Text] [Related]
37. HIV and hepatitis C coinfection: pathogenesis and microbial translocation.
Page EE; Nelson M; Kelleher P
Curr Opin HIV AIDS; 2011 Nov; 6(6):472-7. PubMed ID: 21918438
[TBL] [Abstract][Full Text] [Related]
38. Gender differences in liver fibrosis and hepatitis C virus-related parameters in patients coinfected with human immunodeficiency virus.
Collazos J; Cartón JA; Asensi V
Curr HIV Res; 2011 Jul; 9(5):339-45. PubMed ID: 21827383
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patients.
Merli M; Galli L; Castagna A; Salpietro S; Gianotti N; Messina E; Poli A; Morsica G; Bagaglio S; Cernuschi M; Bigoloni A; Uberti-Foppa C; Lazzarin A; Hasson H
New Microbiol; 2016 Apr; 39(2):110-3. PubMed ID: 27196548
[TBL] [Abstract][Full Text] [Related]
40. During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.
Kostadinova L; Shive CL; Judge C; Zebrowski E; Compan A; Rife K; Hirsch A; Falck-Ytter Y; Schlatzer DM; Li X; Chance MR; Rodriguez B; Popkin DL; Anthony DD
J Infect Dis; 2016 Nov; 214(9):1438-1448. PubMed ID: 27540113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
